Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1152/ajprenal.00127.2014 http://scihub22266oqcxt.onion/10.1152/ajprenal.00127.2014 24944268!7199227!24944268     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Physiol+Renal+Physiol 2014 ; 307 (4): F369-84 Nephropedia Template TP {{tp|p=24944268|t=2014. Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation |pdf=|usr=}}{{24944268}} gab.com Text Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation JO: Am J Physiol Renal Physiol http://www.kidney.de/pget.php?&tw=1&pmid=24944268 #FOAvip Despite its success as a potent antineoplastic agent, approximately 25% of patients receiving cisplatin experience acute kidney injury (AKI) and must discontinue therapy. Impaired magnesium homeostasis has been linked to cisplatin-mediated AKI, and because magnesium deficiency is widespread, we examined the effect of magnesium deficiency and replacement on cisplatin-induced AKI in physiologically relevant older female mice. Magnesium deficiency significantly increased cisplatin-associated weight loss and markers of renal damage (plasma blood urea nitrogen and creatinine), histological changes, inflammation, and renal cell apoptosis and modulated signaling pathways (e.g., ERK1/2, p53, and STAT3). Conversely, these damaging effects were reversed by magnesium. Magnesium deficiency alone significantly induced basal and cisplatin-mediated oxidative stress, whereas magnesium replacement attenuated these effects. Similar results were observed using cisplatin-treated LLC-PK1 renal epithelial cells exposed to various magnesium concentrations. Magnesium deficiency significantly amplified renal platinum accumulation, whereas magnesium replacement blocked the augmented platinum accumulation after magnesium deficiency. Increased renal platinum accumulation during magnesium deficiency was accompanied by reduced renal efflux transporter expression, which was reversed by magnesium replacement. These findings demonstrate the role of magnesium in regulating cisplatin-induced AKI by enhancing oxidative stress and thus promoting cisplatin-mediated damage. Additional in vitro experiments using ovarian, breast, and lung cancer cell lines showed that magnesium supplementation did not compromise cisplatin's chemotherapeutic efficacy. Finally, because no consistently successful therapy to prevent or treat cisplatin-mediated AKI is available for humans, these results support developing more conservative magnesium replacement guidelines for reducing cisplatin-induced AKI in cancer patients at risk for magnesium deficiency. Twit Text FOAVip Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation ????Am J Physiol Renal Physiol http://www.kidney.de/pget.php?&tw=1&pmid=24944268 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24944268 #FOAvip English Wikipedia <ref>{{Cite pmid|24944268}}</ref> Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation #MMPMID24944268 Solanki MH; Chatterjee PK; Gupta M; Xue X; Plagov A; Metz MH; Mintz R; Singhal PC; Metz CN Am J Physiol Renal Physiol 2014[Aug]; 307 (4): F369-84 PMID24944268show ga Despite its success as a potent antineoplastic agent, approximately 25% of patients receiving cisplatin experience acute kidney injury (AKI) and must discontinue therapy. Impaired magnesium homeostasis has been linked to cisplatin-mediated AKI, and because magnesium deficiency is widespread, we examined the effect of magnesium deficiency and replacement on cisplatin-induced AKI in physiologically relevant older female mice. Magnesium deficiency significantly increased cisplatin-associated weight loss and markers of renal damage (plasma blood urea nitrogen and creatinine), histological changes, inflammation, and renal cell apoptosis and modulated signaling pathways (e.g., ERK1/2, p53, and STAT3). Conversely, these damaging effects were reversed by magnesium. Magnesium deficiency alone significantly induced basal and cisplatin-mediated oxidative stress, whereas magnesium replacement attenuated these effects. Similar results were observed using cisplatin-treated LLC-PK1 renal epithelial cells exposed to various magnesium concentrations. Magnesium deficiency significantly amplified renal platinum accumulation, whereas magnesium replacement blocked the augmented platinum accumulation after magnesium deficiency. Increased renal platinum accumulation during magnesium deficiency was accompanied by reduced renal efflux transporter expression, which was reversed by magnesium replacement. These findings demonstrate the role of magnesium in regulating cisplatin-induced AKI by enhancing oxidative stress and thus promoting cisplatin-mediated damage. Additional in vitro experiments using ovarian, breast, and lung cancer cell lines showed that magnesium supplementation did not compromise cisplatin's chemotherapeutic efficacy. Finally, because no consistently successful therapy to prevent or treat cisplatin-mediated AKI is available for humans, these results support developing more conservative magnesium replacement guidelines for reducing cisplatin-induced AKI in cancer patients at risk for magnesium deficiency. |Acute Kidney Injury/*chemically induced/pathology/prevention & control[MESH] |Animals[MESH] |Antineoplastic Agents/*adverse effects[MESH] |Apoptosis/drug effects[MESH] |Blood Urea Nitrogen[MESH] |Cell Line, Tumor[MESH] |Cisplatin/*adverse effects[MESH] |Creatinine/blood[MESH] |Cytokines/biosynthesis[MESH] |Extracellular Signal-Regulated MAP Kinases/metabolism[MESH] |Female[MESH] |Humans[MESH] |Kidney/metabolism[MESH] |LLC-PK1 Cells[MESH] |Magnesium Deficiency/physiopathology[MESH] |Magnesium/metabolism/*therapeutic use[MESH] |Mice[MESH] |Neutrophil Infiltration/*drug effects[MESH] |Oxidative Stress/drug effects[MESH] |Platinum/metabolism[MESH] |STAT3 Transcription Factor/metabolism[MESH]Magnesium protects against cisplatin-induced acute kidney injury by re(epmc).pdf DeepDyve Pubget Overpricing